Thermo Fisher’s BRIMS Center Expands Into Clinical Market, Stays Focused on Academics | GenomeWeb
This story originally appeared in Biocommerce Week, a newsletter that has been discontinued.
Thermo Fisher Scientific’s Biomarker Research Initiative in Mass Spectrometry center said last week that it has expanded its capabilities to include clinical validation and assay development, but for now the center will focus on partnering with academic researchers rather than commercial entities, according to a company official.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: gene flow between ancient chimpanzees and bonobos, and more.

A startup wants to match customers to wine based on their DNA and one critic calls the idea 'silly,' Stat News reports.

Researchers trace the origins of brown rats using genetic analysis to China, the New York Times reports.

In Nature this week: genetic history of HIV in the US, and more.